Search Within

Ross Levine

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (202)
  2. Meeting Abstract (194)
  3. Editorial (11)
  4. Review (9)
  5. Research Letter (5)
  6. Book Section (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Adult Leukemia (426)
  2. Center for Hematologic Malignancies (426)
  3. Center for Molecular Imaging and Biotechnology (426)
  4. Department of Medicine (426)
  5. Executive Committee, Center for Hematologic Malignancies (426)
  6. GSK Faculty (426)

More Groups

People
  1. Martin Tallman (50)
  2. Raajit Rampal (43)
  3. Eytan Stein (40)
  4. Franck Rapaport (28)
  5. Alan Shih (26)
  6. Maria Kleppe (26)

More People

Years
  1. 2024 (9)
  2. 2023 (26)
  3. 2022 (22)
  4. 2021 (25)
  5. 2020 (30)
  6. 2019 (29)

More Years

Publications
  1. Blood (159)
  2. Leukemia (16)
  3. Haematologica (14)
  4. Blood Advances (13)
  5. Cancer Research (12)
  6. Swiss Medical Weekly (11)

More Publications

Publishers
  1. American Society of Hematology (174)
  2. Nature Publishing Group (46)
  3. American Association for Cancer Research (36)
  4. Cell Press (25)
  5. Elsevier Inc. (15)
  6. Ferrata Storti Foundation (14)

More Publishers

Results (426)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
    Journal Article

    Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Pollyea, D. A.; Stone, R. M.; Altman, J. K.; Roboz, G. J.; Patel, M. R.; Collins, R.; Flinn, I. W.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia
    Meeting Abstract

    Annageldiyev, C.; Sharma, A.; Barth, B. M.; Fox, T. E.; Deering, T.; Devine, V.; Keasey, N. R.; Stern, S. T.; Young, M. M.; Wang, H. G. W.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development
    Meeting Abstract

    Uckelmann, H. J.; Kim, S. M.; Antonissen, N. J. C.; Krivtsov, A. V.; Hatton, C.; McGeehan, G. M.; Levine, R. L.; Vassiliou, G. S.; Armstrong, S. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Enasidenib is highly active in previously untreated IDH2 mutant AML: Early results from the Beat AML Master Trial
    Meeting Abstract

    Stein, E. M.; Shoben, A.; Borate, U.; Baer, M. R.; Stock, W.; Patel, P. A.; Kovacsovics, T.; Blum, W.; Vergilio, J. A.; Heerema, N. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A next-generation sequencing-based karyotyping algorithm reveals the genomic structure of acute myeloid leukemia
    Meeting Abstract

    Pavlick, D.; Montesion, M.; Heerema, N. A.; Severson, E. A.; Brennan, T.; Frampton, G. M.; He, J.; Byrd, J. C.; Levine, R. L.; Burd, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Combinatorial genetics uncovers novel targets for the treatment of NPM1/cohesin mutated AML
    Meeting Abstract

    Meyer, A. E.; Stelloh, C.; Fisher, J. B.; Pulakanti, K.; Vassiliou, G. S.; Viny, A. D.; Levine, R. L.; Rao, S.
    Blood (2018)

    Fulltext@MSK | Save
  • A precision medicine heirarchical classification developed using variant allele frequency (VAF) for treatment of older patients (Pts) with acute myeloid leukemia (AML): Alliance Clinical Trials in Oncology (Alliance) historical patient control
    Meeting Abstract

    Mims, A. S.; Kohlschmidt, J.; Borate, U.; Norris, B.; Bucy, T.; Blachly, J. S.; Orwick, S.; Eisfeld, A. K.; Papaioannou, D.; Nicolet, D.; more...
    Blood (2018)

    Fulltext@MSK | Save